期刊文献+

支架置入术对晚期结直肠癌合并急性肠梗阻的临床观察

下载PDF
导出
摘要 目的:分析支架置入术对晚期结直肠癌合并急性肠梗阻的临床效果.方法:2016-04 ~ 2018-01共78例本院收治的晚期结直肠癌合并急性肠梗阻患者,按照随机数字表法将其分为实验组(n=39)、对照组(n=39),给予实验组患者支架置入术治疗,给予对照组患者常规手术治疗治疗,观察两组患者的临床治疗总有效率、术中出血量、手术时间、住院时间,并发症发生率.结果:实验组临床治疗效率高于对照组,术中出血量、手术时间、住院时间,并发症发生率低于对照组(P<0.05).结论:支架置入术对晚期结直肠癌合并急性肠梗阻的临床效果显著,手术时间短,并发症发生率低.
出处 《黑龙江医药科学》 2020年第4期111-112,共2页 Heilongjiang Medicine and Pharmacy
  • 相关文献

参考文献9

二级参考文献63

  • 1王向明,叶金辉,梁卓林,邵剑锋.奥沙利铂联合亚叶酸钙和氟尿嘧啶治疗晚期大肠癌的临床观察[J].中国基层医药,2007,14(4):543-544. 被引量:2
  • 2lyer L,King CD,Whitington PF,et al.Genetic predisposition to the metabolism of irinotecan(CPT-11).Role of uridine diphosphate glucuronosyltransferase isoform 1 A1 in the glucuronidation of its active metabolite(SN-38)in human liver microsomes.J Clin Invest,1998,101(4):847-854.
  • 3Araki E,Ishikawa M,ligo M,et al.Relationship between development of diarrhea and the concentration of SN-38,an active metabolite of CPT-11.in the intestine and the blood plasma of athymic mice following intraperitoneal administration of CPT-11.Jpn J Cancer Res,1993,84(6):697-702.
  • 4Goldberg MR,Rothenberg ML,van Cutsem E.The continnum of care:a paradigm for the management of metastatic colorectal cancer.Oncologist,2007,12(1):38-50.
  • 5Goldberg RM,Sargent DJ,Morton BF,et al.A randomized controlled trial of fluorouracil plus leucovorin,irinotecan,and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.J Clin Oncol.2004,22(1):23-30.
  • 6Douillard J,Cunningham D,Roth A.et al.Irinotecan combined with fluonanacil compared with fluomuracil alone as first-line treatment for metastatic colorectal Cancer:a multicentre randomised trial.The Lancet,2000,355(9209):1041-1047.
  • 7Saltz LB,Clarke S,D(i)az-Rubio E,et al.Randomized phase Ⅲ study of capecitabine plus oxaliplatin compared with fluorouraeil/ folinic acid plus oxaliplafin as first-line therapy for metastatic colorectal cancel.J Clin Oncol,2008,26(12):2006-2012.
  • 8Cunniagham D,Humblet Y,Siena S,et al.Cetuximab monotherapy and celuximab plus irinotecan in irinotecan-refractory metastatic coloreclal cancer N Engl J Med,2004,351(4):337-345.
  • 9Hurwitz H,Fehrenbacher L,Novotny W,et al.Bevacizumab plus irinotecan,fluoronracil,and leucovorin for metastatic colorectal cancer.N Engl J Med,2004,350(23):2335-2342.
  • 10Therasse P,Arbuck SG,Eisenhauer EA,et al.New guidelines to evaluate the response to treatment in solid tumors(BECIST Guidelines).J Natl Cancer lnst,2000,92(3):205-216.

共引文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部